AlphaGen Therapeutics

AlphaGen Therapeutics Ltd, a Shanghai-based developer specializing in radioligand therapy (RLT), has reportedly secured “tens of millions” of US dollars in a seed financing round co-led by Eight Roads. The funds will be instrumental in accelerating the clinical development of the company’s Pb-212 pipeline and in constructing a state-of-the-art radiopharmaceutical…